Physiogenex is committed to staff protection and to ethical use of animals in research
Regulatory bodies worldwide, including the European medicines agency (EMEA) and the US Food and Drug Administration, require that most drugs be thoroughly evaluated both in vitro and in animals before approval for human use.
Staff Protection
Physiogenex scrupulously respects local and international human safety standards. Manipulation of all chemical products respects institutional and national regulations, thereby ensuring staff safety and environmental protection. All personnel handling biohazardous materials receive appropriate training. Disposal of hazardous waste complies with EC regulations. Institutional safety officers are charged with ensuring that safety rules are fully respected.
Use of Laboratory Animals
Physiogenex uses a state-of-the-art animal house staffed by trained technicians. All national rules and regulations governing animal care are fully respected.
All experimental studies conducted by Physiogenex comply fully with directive 89/391/EC. The animal house also adheres to guidelines published by the Federation of European Laboratory Animal Science Association (FELASA) concerning the well-being of experimental animals.
Physiogenex has received official authorization to conduct animal experimentation. Breeding and housing conditions are carefully controlled in order to minimize animal stress.
Furthermore, Physiogenex has taken the initiative to seek new ways of minimizing the use of experimental animals, notably by developing more sensitive methods that require fewer animals per group, and by scrupulously applying the "3Rs" principle:
- Refine—Eliminate or minimize impact to animals by reducing potentially painful or invasive procedures, whenever possible
- Reduce—Use the absolute minimum number of animals in each study necessary to obtain valid results
- Replace—Always look for alternative, non-animal-based research methods where possible